Torbjörn Wärnheim
Geen lopende functies
Vermogen: 12 873 $ op 30-04-2024
Profiel
Torbjörn Wärnheim worked as an Executive VP and Manager of Research & Development at Moberg Pharma AB from 2019 to 2021.
He also worked as a Vice President of Research & Development at Fresenius Kabi AB.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
OLINK HOLDING AB
0.00% | 05-02-2024 | 558 ( 0.00% ) | 12 873 $ | 30-04-2024 |
Eerdere bekende functies van Torbjörn Wärnheim
| Bedrijven | Functie | Einde |
|---|---|---|
| MOBERG PHARMA AB | Hoofd Techniek/Wetenschap/O&O | 01-09-2021 |
Fresenius Kabi AB
 Fresenius Kabi AB Medical SpecialtiesHealth Technology Fresenius Kabi AB specializes in clinical nutrition, infusion therapy, and medical technology. It offers products for the collection and treatment of blood components and for the treatment of patient blood through therapeutic apheresis. The firm also develops products with a focus on oncology and autoimmune diseases. The company is headquartered in Uppsala, Sweden. | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MOBERG PHARMA AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Fresenius Kabi AB
Fresenius Kabi AB Medical SpecialtiesHealth Technology Fresenius Kabi AB specializes in clinical nutrition, infusion therapy, and medical technology. It offers products for the collection and treatment of blood components and for the treatment of patient blood through therapeutic apheresis. The firm also develops products with a focus on oncology and autoimmune diseases. The company is headquartered in Uppsala, Sweden. | Health Technology |
